Boston Scientific Corporation BSX
43.92
(0.76)
(1.70%)
as of 25 Sep
- Market cap
- $64.7B
- P/E
- 17.7×
Follow BSX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Boston Scientific Corporation (BSX) P/E ratio
As of 25 September 2026, Boston Scientific Corporation (BSX) trades at a P/E ratio of 17.7×. Over the past ten years it has ranged from 0.0× (March 2021) to 442× (April 2021); the current reading is higher than 20% of that period. That is below the Medical Devices industry median of 22.2× and below the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 48.6× | (31.37%) |
| FY2024 | 70.9× | 31.14% |
| FY2023 | 54.1× | (47.13%) |
| FY2022 | 102× | 66.07% |
| FY2021 | 61.6× | — |
| FY2020 | 0.0× | — |
| FY2019 | 13.4× | (54.19%) |
| FY2018 | 29.2× | (90.76%) |
| FY2017 | 316× | 275.50% |
| FY2016 | 84.2× | — |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 17.2× | (34.18%) |
| Mar 2026 | 26.1× | (46.26%) |
| Dec 2025 | 48.6× | (5.82%) |
| Sep 2025 | 51.7× | (18.24%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 442×
Ten-year median
62.7×
Current reading's percentile
20
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| BSX Boston Scientific Corporation | 17.7× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| MDT Medtronic PLC compare | 21.7× |
| STE STERIS plc compare | 25.4× |
| SYK Stryker Corporation compare | 28.0× |
| ABT Abbott Laboratories compare | 32.8× |
| DXCM DexCom, Inc. compare | 33.4× |
| EW Edwards Lifesciences Corporation compare | 49.6× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on BSX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement